Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide.
If you are interested in BAYN stock information, you might also be interested in competitors like NasdaqGS:COST.
The market capitalization of Bayer is currently at 53.20€ B. This places it among the high capitalized companies.
The book value reported in the balance sheet results in a P/B ratio of 1.4.
With one share of Bayer investors achieved a dividend of 2.00€. This results in a good dividend yield of 3.69%. In the last 13 years, the annual dividend has risen constantly.
For the risk analysis, the high beta factor should be noted, which is currently at a value of 1.15. The price of the stock XTRA:BAYN is therefore subject to relatively strong fluctuations in relation to the overall market.
For Wall Street analysts, a price target of 67.79€ is currently considered realistic.
XTRA:BAYN has a 52 week range of 43.91€ - 67.99€ and is currently trading around 54.15€.
The low short sale ratio indicated that the value might increase in the foreseeable future.